HIV-1 subtype diversity in Minnesota

被引:31
作者
Sides, TL
Akinsete, O
Henry, K
Wotton, JT
Carr, PW
Bartkus, J
机构
[1] Minnesota Dept Hlth, Minneapolis, MN 55414 USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
关键词
D O I
10.1086/430322
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Genetic variation in human immunodeficiency virus (HIV)-1 poses significant public-health and clinical challenges. In North America, subtype B is most prevalent. HIV-1 subtyping is not integrated into routine HIV/acquired immunodeficiency syndrome surveillance in the United States. In 2003, the Minnesota Department of Health piloted HIV-1 subtyping with routine surveillance to describe the existence and variety of non-subtype B strains. Methods. Targeted HIV-1 subtype surveillance was conducted on 98 African-born HIV-infected patients. Sentinel subtype surveillance was conducted in a Minneapolis sexually transmitted disease clinic on 28 newly diagnosed non-African HIV-positive patients. Subtype determination was based on a partial sequence of the gp41 region of the HIV-1 env gene. Results. Subtyping was successful for 87 of 98 samples from African-born HIV-infected patients; 95% were non-B subtypes. The 7 subtypes observed were consistent with strains endemic in patients' birth regions. Subtyping was also completed for samples from 25 of 28 non-African-born patients; all were subtype B. Conclusions. Multiple HIV-1 subtypes are present in Minnesota. Our data suggest that most of the HIV cases in Minnesota among African-born patients are non-B subtypes. Population-based surveillance inclusive of groups at high risk for variant strains is needed to monitor the prevalence and variety of HIV subtypes in the United States.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 74 条
[1]   Polymorphism in protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant CRFO2_AG isolates from patients with no prior use of Antiretroviral drugs in Abidjan, Cote d'Ivoire [J].
Adjé-Touré, C ;
Bilé, CE ;
Borget, MY ;
Hertog, K ;
Maurice, C ;
Nolan, ML ;
Nkengasong, JN .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (01) :111-113
[2]   K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1 [J].
Akinsete, O ;
Hirigoyen, D ;
Cartwright, C ;
Schut, R ;
Kantor, R ;
Henry, K .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) :575-578
[3]   Most HIV-1 genetic subtypes have entered Sweden [J].
Alaeus, A ;
Leitner, T ;
Lidman, K ;
Albert, J .
AIDS, 1997, 11 (02) :199-202
[4]   Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (Subtype E) infection differ from subtype B infection [J].
Ariyoshi, K ;
Matsuda, M ;
Miura, H ;
Tateishi, S ;
Yamada, T ;
Sugiura, W .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (03) :336-342
[5]   AT LEAST 5 HIV-1 SEQUENCE SUBTYPES (SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, SUBTYPE-D, SUBTYPE-A/E) OCCUR IN ENGLAND [J].
ARNOLD, C ;
BARLOW, KL ;
PARRY, JV ;
CLEWLEY, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :427-429
[6]   Recombinant strains of HIV type 1 in the United Kingdom [J].
Barlow, KL ;
Tatt, ID ;
Cane, PA ;
Pillay, D ;
Clewley, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (05) :467-474
[7]  
BEATRICE S, 1998, 12 INT AIDS C GEN
[8]  
BEATRICE ST, 2000, 7 C RETR OPP INF SAN, P107
[9]  
Böni J, 1999, J ACQ IMMUN DEF SYND, V22, P174
[10]   Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda [J].
Brennan, CA ;
Lund, JK ;
Golden, A ;
Yamaguchi, J ;
Vallari, AS ;
Phillips, JF ;
Kataaha, PK ;
Jackson, JB ;
Devare, SG .
AIDS, 1997, 11 (15) :1823-1832